The 2026 EULAR guideline on Management of Rheumatoid Arthritis with Synthetic and Biologic Disease-Modifying Antirheumatic Drugs, summarizing key recommendations on DMARD therapy, treatment targets, and more.

• Management of Rheumatoid Arthritis with Synthetic and Biologic Disease-Modifying Antirheumatic Drugs

• European League Against Rheumatism (EULAR)

• March 13 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5135295

• Full-Text: https://ard.eular.org/article/S0003-4967(26)00075-0/fulltext

The 2026 AACE consensus statement on Algorithm for Management of Adults With Type 2 Diabetes, including a new classification algorithm and updated guidance.

• Algorithm for Management of Adults With Type 2 Diabetes – 2026 Update

• American Association of Clinical Endocrinologists

• March 3, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5139655/

• Full-Text: https://www.endocrinepractice.org/article/S1530-891X(26)00022-4/fulltext#author-abstract

The 2026 Venous Origin Chronic Pelvic Pain in Women guideline, highlighting key guidance statements across management, complications, surgical interventions, and more.

• Venous Origin Chronic Pelvic Pain in Women

• Society of Interventional Radiology

• March 3rd, 2026

• Guideline Summary: https://www.guidelinecentral.com/guideline/5122930/

• Full-Text: https://www.jvir.org/article/S1051-0443(25)00794-8/pdf